Appili Therapeutics Inc (APLI) — Strategic Asset Allocation Index
Appili Therapeutics Inc (APLI) has a Strategic Asset Allocation Index of 0.9% as of June 2021. Strategic assets (PP&E of CA$51.88K plus long-term investments of CA$-) total CA$51.88K, measured against net assets of CA$5.86 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See APLI equity to assets ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Appili Therapeutics Inc Strategic Asset Allocation Index (2017–2021)
This chart shows how Appili Therapeutics Inc's Strategic Asset Allocation Index has evolved across 5 annual periods from 2017 to 2021. As of June 2021, the index stands at 0.9%, representing strategic assets of CA$51.88K against net assets of CA$5.86 Million CAD. For live market cap and overall valuation, see Appili Therapeutics Inc market capitalisation.
Annual Strategic Asset Allocation Index for Appili Therapeutics Inc (2017–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Appili Therapeutics Inc from 2017 to 2021, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Appili Therapeutics Inc shareholders equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CAD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 0.4% | CA$54.99K | CA$54.99K | CA$- | CA$12.75 Million | ▼ -0.3 pp |
| 2020 | 0.7% | CA$63.31K | CA$63.31K | CA$- | CA$8.85 Million | ▼ -1.1 pp |
| 2019 | 1.8% | CA$79.98K | CA$79.98K | CA$- | CA$4.42 Million | ▼ 0.0 pp |
| 2018 | 1.8% | CA$88.39K | CA$88.39K | CA$- | CA$4.87 Million | ▼ -2.0 pp |
| 2017 | 3.9% | CA$53.00K | CA$53.00K | CA$- | CA$1.37 Million | — |